Hypertension Diagnostics (HDII) Short Interest Ratio & Short Volume

Short interest is the volume of Hypertension Diagnostics shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 9,700 shares of HDII short. Learn More on Hypertension Diagnostics' current short interest.

Hypertension Diagnostics saw a decline in short interest in August. As of August 15th, there was short interest totaling 9,700 shares, a decline of 83.8% from the previous total of 59,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "medical equipment" compare to Hypertension Diagnostics: RenovaCare, Inc. (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($4.13 billion), Charter Communications, Inc. ($3.94 billion), Coinbase Global, Inc. ($2.38 billion), Lucid Group, Inc. ($2.30 billion), T. Rowe Price Group, Inc. ($2.22 billion), Williams-Sonoma, Inc. ($2.02 billion), Plug Power Inc. ($1.94 billion), Chesapeake Energy Co. ($1.91 billion), Unity Software Inc. ($1.82 billion), and Rivian Automotive, Inc. ($1.74 billion). View all of the most shorted stocks.

Short selling HDII is an investing strategy that aims to generate trading profit from Hypertension Diagnostics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Hypertension Diagnostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HDII, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HDII, twice per month. The most recent reporting period available is August, 15 2022.